Does Rocking Charis Calm Delirious Patients in the Intensive Care Unit
RocingICU
Does ROCKING Chairs Calm Delirious Patients in the Intensive Care Unit: a Multicenter Clinical Randomized Trial (RockingICU)
1 other identifier
interventional
152
1 country
1
Brief Summary
Background: Delirium among patients admitted to an ICU is a common condition associated with increased morbidity and mortality. To this point no evidence-based prevention or treatment exist for delirium. Non-pharmacological interventions such as early mobilization and systematic bundle of care have been suggested to decrease the number of days of delirium. So far there exist no studies exploring if delirious patients benefit or not when mobilized to a rocking chair with music therapy. Objectives: To assess if rocking chair therapy can decrease the burden of delirium in adult, critical ill patients admitted to an ICU. Design: A clinical initiated multicenter randomized non-blinded trial, of delirious patients mobilized to a rocking chair versus no rocking chair. Inclusion and exclusion criteria: Inclusion criteria: Adult intensive care patients (18 years and above) diagnosed with delirium with a validated screening tool. Exclusion criteria: if the patient is evaluated not to be mobilized to a rocking chair and expressing discomfort and do not wish to be mobilized, a patient with critical illness neuropati, patients with lever coma, patient in ECM treatment, patients that are mentally permanently incompetent, not receiving active life support if needed, weight more that 130 kg, if informed consent cannot be obtained, if the patient is admitted because of suicide attempt and is the patient have delirium tremens. Intervention: The experimental intervention is a 20 min. long rocking chair with music therapy. Control intervention is also transferred to the rocking chair, but the therapy program will not be turned on. Standardized pharmacological and non-pharmacological interventions for delirium will continue for both groups. Delirium and consciousness will be evaluated twice a day. Outcomes: Primary outcome: number of days alive without coma and delirium in the ICU. Secondary outcome: Number of days admitted to the ICU and number of patients with at least one difference in RASS score before end after the experimental intervention. Trial size: A power calculation have estimated that a total number of 76 patients with delirium should be included in each study group. Time schedule: We estimate that the inclusion period and follow up will as long as 1 year from the time the first patient is randomized. Amendment's protocol Agreed by the project group August 22nd 2022, we will do an additional 90-day follow-up of all-cause mortality. This was agreed before the project group or statistician had access to the randomisation key and intervention data, and before any statistical analysis was started.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2019
CompletedFirst Posted
Study publicly available on registry
May 26, 2020
CompletedStudy Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 13, 2022
CompletedMarch 19, 2024
March 1, 2024
2.5 years
November 4, 2019
March 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
number of days alive without coma and delirium in the ICU
14 day follow up
Secondary Outcomes (3)
Number of days admitted to the ICU
14 day follow up
Delta RASS
14 day follow up
all cause mortality
90 day follow up
Study Arms (2)
Experiemntal intervention
EXPERIMENTALThe experimental intervention is a 20 min. long rocking chair with music therapy.
Control intervention
ACTIVE COMPARATORControl intervention is also transferred to the rocking chair, but the therapy program will not be turned on.
Interventions
20 min long rocking therapy with music cure. The therapy can be extended if needed
Eligibility Criteria
You may qualify if:
- admitted to ICU
- positive delirium evaluation with CAM-ICU or ICDSC
You may not qualify if:
- if the patient is evaluated not to be mobilized to a rocking chair
- expressing discomfort and do not wish to be mobilized
- patients with critical illness neuropathy
- patients with levercoma
- patient in ECOM (exstracorporel membrane oxygenation) treatment
- patients that are mentally permanently incompetent
- patients not receiving active life support if needed
- patients that weight more than 130 kg
- patients were informed consent cannot be obtained
- patients admitted because of suicide attempt
- patients with delirium tremens
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Copenhagen University Hospital, Rigshospitalet
Copenhagen, 2100, Denmark
Related Publications (1)
Collet MO, Nielsen GM, Thorn L, Laerkner E, Fischer S, Bang B, Langvad A, Granholm A, Egerod I. Rocking Motion Therapy for Delirious Patients in the ICU: A Multicenter Randomized Clinical Trial. Crit Care Med. 2025 Jan 1;53(1):e161-e172. doi: 10.1097/CCM.0000000000006495. Epub 2024 Nov 15.
PMID: 39792532DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ingrid Egerod, Professor
Department of Intensive care, Copenhagen University Hospital, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 4, 2019
First Posted
May 26, 2020
Study Start
June 1, 2020
Primary Completion
November 13, 2022
Study Completion
November 13, 2022
Last Updated
March 19, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share